🔎 Trials Near Me

Home › Urothelial (Transitional Cell) Carcinoma › Michigan › Detroit

Pag-aaral pangklinika para sa Urothelial (Transitional Cell) Carcinoma sa Detroit, MI

6 pag-aaral para sa Urothelial (Transitional Cell) Carcinoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Detroit (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Nagre-recruitPhase 1
  • Exelixis Clinical Site #65, Detroit
  • Exelixis Clinical Site #13, Detroit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT05176483

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Nagre-recruitPhase 2
  • Henry Ford Hospital, Detroit
  • Henry Ford Health Saint John Hospital, Detroit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT03866382

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Nagre-recruitPhase 3
  • Karmanos Cancer Institute, Detroit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07218380

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Nagre-recruitPhase 1
  • Karmanos Cancer Institiute, Detroit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06293898

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Nagre-recruitPhase 1/2
  • Henry Ford Cancer Institute, Detroit
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT04198766

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Nagre-recruitPhase 2
  • Karmanos Cancer Institute, Detroit
  • Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion), Detroit
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT04879329

Pag-aaral para sa Urothelial (Transitional Cell) Carcinoma sa ibang lungsod

Iba pang pag-aaral sa Detroit

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.